Match Document Document Title
7629318 Immunosuppressant compounds, methods and uses related thereto  
The present invention relates to compositions and methods for suppressing an immune response, e.g., by inhibiting class II MHC-mediated activation of T cells. The subject compounds and methods may...
7622551 Leukocyte stimulating peptides  
The present application describes peptides that stimulate arachidonic acid release in target cells. The application also discloses peptides that cause intracellular calcium release. The application...
7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV  
The present invention comprises novel and modified peptides capable of inducing a HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective...
7611711 VEGFR-3 inhibitor materials and methods  
The present invention relates to the diagnosis, evaluation, and therapeutic intervention of disorders mediated by the activity of cell surface receptor VEGFR-3, which activity often is stimulated...
7605150 Drug therapy for Celiac Sprue  
Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic effects of toxic gluten oligopeptides, thereby attenuating or eliminating the...
7605133 Isolated peptides to treat alpha-synuclein diseases  
The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by α-synuclein aggregation. These methods are especially useful in the design and...
7601693 Composition for treating cancer and use thereof  
The present invention provides a cyclic peptide containing RRXR motif. The present invention also provides a composition comprising the said cyclic peptide and a pharmaceutical acceptable carrier....
7598342 Alpha-fetoprotein peptides and uses thereof  
The invention relates to compounds that include peptide and peptidomimetics that inhibit estrogen receptor dependent cell proliferation. The compounds of the invention are useful for treating cell...
7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs  
The invention provides a conjugate that includes a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to vasculature of premalignant pancreas. The peptide or...
7592009 Polypeptide ligands for targeting cartilage and methods of use thereof  
Ligands that specifically bind to articular cartilage tissues are disclosed, including uses for targeting therapeutics towards articular cartilage tissue and new materials for articular cartilage....
7589058 Ghrelin analogs  
The invention comprises peptidyl analogs that possess agonist or antagonist ghrelin activity, along with therapeutic and non-therapeutic uses thereof.
7585509 Erb-2 receptor targeting peptide  
The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides...
7582725 Agents, which inhibit apoptosis in cells that are involved in wound healing  
The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin α v...
7582461 Kinase and phosphatase assays  
Compositions, methods, and kits for detecting and monitoring kinase or phosphatase activity are described. The compositions typically include a peptide, a detectable moiety, and a protease cleavage...
7579436 Peptide compound for measuring sulfur compound and ammonia  
A peptide compound for measuring sulfur compound and ammonia and measurement method and device using the compound. The method comprises contacting an analyte with a sensory device coated with the...
7579435 Somatostatin-dopamine chimeric analogs  
Disclosed is a series of somatostatin-dopamine chimeric analogs which retain both somatostatin and dopamine activity in vivo. An example is:...
7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis  
Methods, compositions and devices are disclosed for use in growing new blood vessels to restore or improve blood flow to ischemic tissues and organs of the body. Compositions comprising IGD...
7579320 IAP BIR domain binding compounds  
Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II or a salt thereof, in which R 1 , R 2 , R 3 , R 100 , R 200 , R 300 , A, A 1 , BG, Q...
7579165 Methods for derivatizing protein or peptide with sulfonic acid groups  
The present invention provides a method for effectively introducing sulfonic acid groups into the N-terminus of a protein or a peptide. The method comprises a modification step to react a...
7576175 Alpha-4 beta-1 integrin ligands for imaging and therapy  
The present invention provides α 4 β 1 integrin ligands that display high binding affinity, specificity, and stability. The ligands comprise a peptide having n independently selected amino...
7575881 Modulation of nitric oxide signaling through signaling through specific regulation by arginylation and the N-end rule pathway  
Screening assays that allow for the identification of agents that modulate the activity of the arginylation branch of the N-end rule pathway are provided. Also provided are method of using an agent...
7572884 Method for making acylated polypeptides  
The present invention related to a method of producing polypeptides in transformed host cells by expressing a precursor molecule of the desired polypeptide which are to be acylated in a subsequent...
7572883 Somatostatin-dopamine chimeric analogs  
Disclosed is a series of somatostatin-dopamine chimeric analogs which retain both somatostatin and dopamine activity in vivo. An example is: ...
7569547 Inhibiting furin with polybasic peptides  
Small, polybasic peptides are disclosed that are effective as furin inhibitors, e.g. hexa- to nona-peptides having L-Arg or L-Lys in most positions. Removing the peptide terminating groups can...
7569231 Method for stabilizing oil-based thickening gel composition  
The present invention relates to (1) a stabilized oil-based thickening gel composition comprising (a) an anionic surfactant having a lipopeptide structure, (b) water and/or a polyhydric alcohol...
7557087 Compositions and methods for treating diseases  
This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of...
7550438 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells  
Novel growth peptides derived from protein factors having molecular weights of about 22 and 45 kDa stimulate mitogenic activity of epithelial, but not fibroblastic cells, in particular, kidney...
7547676 Antagonist peptides to the C5A chemotactic function of vitamin D binding protein  
It has been demonstrated that one of Vitamin D Binding Protein (DBP) biological functions is to enhance the chemotactic activity of C5 a and C5 a des Arg. The present invention has found that...
7544781 Polypeptide and process for producing the same  
A process for producing a polypeptide, by reacting a peptide component (A) represented by formula (1) below with a peptide component (B) represented by formula (2) below and optionally a compound...
7544774 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX  
The present invention is directed to an isolated peptide that functionally mimics a binding site for a monoclonal antibody, the monoclonal antibody recognizing an epitope within the human platelet...
7544773 Antimicrobials against pathogenic bacteria and method for screening them  
The present invention provides antimicrobials for efficient therapy of infections caused by bacterial pathogens. The antimicrobials include peptides corresponding to the active site of N-terminal...
7544772 Methods for regulating inflammatory mediators and peptides useful therein  
The present invention includes methods of modulating cellular secretory processes. More specifically the present invention relates to modulating or reducing the release of inflammatory mediators...
7541430 Peptides for use in treating obesity  
Novel cyclic and linear peptides of the formula R 1 —X—X 1 —X 2 —X 3 —X 4 —X 5 —X 6 —X 7 —X 8 —X 9 —X 10 —X 11 —R 2 are useful in the treatment of obesity are provided.
7541429 Comparative ligand mapping from MHC positive cells  
The present invention relates generally to a methodology for the isolation, purification and identification of peptide ligands presented by MHC positive cells. In particular, the methodology of the...
7538188 Method for fabricating an olfactory receptor-based biosensor  
A biosensor, a method of making a biosensor, and a method of using a biosensor are described. A biosensor includes a transducer and a peptide encoding the most probable binding domain of an...
7538089 Anti-inflammatory compounds and uses thereof  
The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides...
7538083 Compositions and methods for the potentiation of immune responses against target antigens  
The present invention provides novel adjuvant systems for the potentiation of immune responses against antigenic targets.
7534438 Product and process for liquefaction of mucus or sputum  
Disclosed are compositions and methods for decreasing the viscosity and/or cohesiveness of and/or increasing the liquefaction of excessively or abnormally viscous or cohesive mucus or sputum. The...
7534431 Methods and compositions for administering therapeutic and diagnostic agents  
Methods and compositions are described for targeting therapeutic and diagnostic molecules to particular types of cells using targeting antibodies or other targeting moeities.
7531624 Nuclear targeting sequence  
The present provides nuclear localization signaling (NLS) sequences derived from titin, comprised of amino acids 181-220: SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR and fragments thereof, such as...
7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells  
A method for preparing a grafted homodetic cyclopeptide forming a framework that defines a grafted upper face and grafted lower face, including synthesizing a linear peptide from modified or...
7531516 Peptidic compounds selectively binding to P-selectin  
The present invention relates to compounds which bind selectively to the adhesion molecule human P-selectin, and particularly to such compounds comprising a peptide with an amino acid sequence XA x...
7528227 Histone H2A peptide derivatives and uses thereof  
Peptides derived from a segment of human histone H2A, the segment corresponding to amino acid residues 36-44 of human histone H2A, are capable of reducing or ameliorating the extent of injury...
7528226 TGFβ1-inhibitor peptides  
Antagonistic synthetic peptides, obtained from TGFβ1 or from its receptors in the organism, that can be used in the manufacture, both on their own, as well as the gene sequences that encode them...
7524926 Mucin hypersecretion inhibitors and methods of use  
Peptides are provided that comprise less than 24 amino acids. The peptides have an amino acid sequence selected from the group consisting of: (a) an amino acid sequence having from 4 to 23...
7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor  
The invention relates to compositions which are useful for inhibiting prostaglandin F 2α receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and...
7517857 Immune-modulating peptide  
Disclosed are peptides having SEQ ID NOs: 1 to 24 that induce superoxide generation by human monocytes or neutrophils; that induce an intracellular calcium increase by human peripheral blood...
7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof  
The present invention relates generally to peptides, which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, methods of making peptides, which inhibit angiogenesis, cell...
7517654 Peptide and a derivative thereof promoting cell adhesion and spreading  
The present invention relates to a peptide promoting cell adhesion and spreading, fragments, and derivatives thereof, more particularly, integrin-α3β1-dependent peptide in human laminin-5 α3...
7514408 β-secretase enzyme compositions and methods  
Disclosed is an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of...